INDIGO Linking Program
INDIGO POLICY LINKING PROGRAMME CALL - BIOTECHNOLOGY IN THE FIELD OF HEALTH
Three multilateral projects in the field of biotechnology (health) have been selected for funding by the INDIGO POLICY Steering Board Committee from a total of 18 project proposals under the framework of the INDIGO POLICY Linking Programme. Each project will receive up to EUR 30,000 for a duration of 18 months (March 2015 – August 2016).
The main goal of the INDIGO POLICY Linking Programme is to support a sustainable multilateral cooperation involving a minimum of 2 European and 1 Indian research teams. The latter should aim to establish a virtual multilateral laboratory. INDIGO POLICY will support the first steps of the cooperation. It will fund mobility activities to set up the virtual multilateral laboratory where project partners will share human and material resources while they will keep their autonomy, their status, and their separated location.
The projects will be financially supported with a maximum seed grant of EUR 30 000 per project. Moreover, INDIGO POLICY will bring assistance to the projects partners to secure the funding of the projects’ second phase (July 2016 – June 2018).
Up to 5 partners are involved per project.
Coordinator: Italian Research Council (CNR)
Partners: Imperial College London (United Kingdom) & International Center for Genetic Engineer and Biotechnology (India)
Detailed subject area: Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis, causes approximately 2 million deaths worldwide. Drug development against TB, planned in this project, is a strong and urgent need.
Coordinator: University of Twente (The Netherlands)
Partners: University of Bern (Switzerland) & Indian Institute of Science (IISc), Bangalore
Detailed subject area: Towards real-time quantitative photoacoustic imaging of vascular abnormalities for near-future application in oncology.
Coordinator: French National Center for Scientific Research (CNRS)
Partners: University of Bern (Switzerland), International Center for Genetic Engineer and Biotechnology (ICGEB, India), Technical University of München (Germany), All India Institute of Medical Sciences (AIIMS, India)
Detailed subject area: Understanding organelle dynamics in Apicomplexan parasites to identify novel drug targets: cellular and molecular events in Plasmodium (malaria agent) and Toxoplasma, during biogenesis and maintenance of two essential intracellular organelles of algal and prokaryotic origins, the apicoplast and the mitochondrion.
Ms. Sarah Diemu-Tremoliers –CNRS